Abstract

Mutations in KCNC3, which encodes the Kv3.3 potassium channel, cause degeneration of the cerebellum, but exactly how the activity of an ion channel is linked to the survival of cerebellar neurons is not understood. Here, we report that Kv3.3 channels bind and stimulate Tank Binding Kinase 1 (TBK1), an enzyme that controls trafficking of membrane proteins into multivesicular bodies, and that this stimulation is greatly increased by a disease-causing Kv3.3 mutation. TBK1 activity is required for the binding of Kv3.3 to its auxiliary subunit Hax-1, which prevents channel inactivation with depolarization. Hax-1 is also an anti-apoptotic protein required for survival of cerebellar neurons. Overactivation of TBK1 by the mutant channel leads to the loss of Hax-1 by its accumulation in multivesicular bodies and lysosomes, and also stimulates exosome release from neurons. This process is coupled to activation of caspases and increased cell death. Our studies indicate that Kv3.3 channels are directly coupled to TBK1-dependent biochemical pathways that determine the trafficking of cellular constituents and neuronal survival.

How the activity of the neuronal Kv3.3 voltage-dependent channel is regulated is unclear. Here, the authors show that the known Kv3.3 channel complex with Hax1, which affects spinal cerebellar ataxia, regulates the enzyme Tank Binding Kinase 1, modulating survival of cerebellar neurons.

Details

Title
Cerebellar Kv3.3 potassium channels activate TANK-binding kinase 1 to regulate trafficking of the cell survival protein Hax-1
Author
Zhang, Yalan 1 ; Varela, Luis 2 ; Szigeti-Buck Klara 2 ; Williams, Adam 3 ; Stoiljkovic Milan 2 ; Šestan-Peša Matija 2   VIAFID ORCID Logo  ; Henao-Mejia, Jorge 4 ; D’Acunzo Pasquale 5   VIAFID ORCID Logo  ; Levy, Efrat 6 ; Flavell, Richard A 7   VIAFID ORCID Logo  ; Horvath, Tamas L 2   VIAFID ORCID Logo  ; Kaczmarek, Leonard K 8   VIAFID ORCID Logo 

 Yale University School of Medicine, Department of Pharmacology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Yale University School of Medicine, Department of Immunobiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); The Jackson Laboratory, The Jackson Laboratory for Genomic Medicine, Farmington, USA (GRID:grid.249880.f) (ISNI:0000 0004 0374 0039) 
 Yale University School of Medicine, Department of Immunobiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); University of Pennsylvania, Children’s Hospital of Philadelphia, Department of Pathology and Laboratory Medicine, Institute for Immunology, Perelman School of Medicine, Philadelphia, USA (GRID:grid.47100.32) 
 The Nathan S. Kline Institute for Psychiatric Research, Center for Dementia Research, Orangeburg, USA (GRID:grid.250263.0) (ISNI:0000 0001 2189 4777); New York University School of Medicine, Department of Psychiatry, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753) 
 The Nathan S. Kline Institute for Psychiatric Research, Center for Dementia Research, Orangeburg, USA (GRID:grid.250263.0) (ISNI:0000 0001 2189 4777); New York University School of Medicine, Department of Psychiatry, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753); New York University School of Medicine, NYU Neuroscience Institute, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753); New York University School of Medicine, Department of Biochemistry & Molecular Pharmacology, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753) 
 Yale University School of Medicine, Department of Immunobiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Howard Hughes Medical Institute, Chevy Chase, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581) 
 Yale University School of Medicine, Department of Pharmacology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale School of Medicine, Department of Cellular and Molecular Physiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2503047521
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.